Compare PL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PL | ICLR |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | Ireland |
| Employees | 970 | N/A |
| Industry | Aerospace | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 9.3B |
| IPO Year | N/A | 2001 |
| Metric | PL | ICLR |
|---|---|---|
| Price | $41.29 | $116.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $27.64 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 7.8M | 1.4M |
| Earning Date | 06-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.29 | N/A |
| Revenue Next Year | $30.22 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.47 | $66.57 |
| 52 Week High | $43.31 | $211.00 |
| Indicator | PL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 51.54 |
| Support Level | $32.23 | $99.11 |
| Resistance Level | $41.71 | $116.85 |
| Average True Range (ATR) | 3.73 | 6.50 |
| MACD | 0.21 | -0.28 |
| Stochastic Oscillator | 65.91 | 37.92 |
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.